Furthermore, the patient populations prescribed various GLP-1 receptor agonists differ, possibly influencing the risk of asthma-related adverse events (considering factors such as age, comorbidities, preexisting respiratory conditions, smoking status, genetic predisposition). Here, GLP1R is linked to asthma.